<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Antioxid Redox Signal</journal-id>
<journal-id journal-id-type="iso-abbrev">Antioxid. Redox Signal</journal-id>
<journal-id journal-id-type="publisher-id">ars</journal-id>
<journal-title-group>
<journal-title>Antioxidants &amp; Redox Signaling</journal-title>
</journal-title-group>
<issn pub-type="ppub">1523-0864</issn>
<issn pub-type="epub">1557-7716</issn>
<publisher>
<publisher-name>Mary Ann Liebert, Inc., publishers</publisher-name>
<publisher-loc>140 Huguenot Street, 3rd FloorNew Rochelle, NY 10801USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29634350</article-id>
<article-id pub-id-type="pmc">6393771</article-id>
<article-id pub-id-type="publisher-id">10.1089/ars.2017.7321</article-id>
<article-id pub-id-type="doi">10.1089/ars.2017.7321</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Comprehensive Invited Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Redox Mechanisms in Neurodegeneration: From Disease Outcomes to Therapeutic Opportunities</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Sbodio</surname>
<given-names>Juan I.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Snyder</surname>
<given-names>Solomon H.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1,</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2,</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="corr1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Paul</surname>
<given-names>Bindu D.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="corr2"></xref>
</contrib>
<aff id="aff1"><label><sup>1</sup></label>The Solomon H. Snyder Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, Maryland.</aff>
<aff id="aff2"><label><sup>2</sup></label>Department of Pharmacology and Molecular Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland.</aff>
<aff id="aff3"><label><sup>3</sup></label>Department of Psychiatry, The Johns Hopkins University School of Medicine, Baltimore, Maryland.</aff>
</contrib-group>
<author-notes>
<fn fn-type="other" id="fn1">
<p>Reviewing Editors: <italic>Vsevolod Belousov, Pamela Maher, Jeremy Marks, Pier Mastroberardino, Rituraj Pal, and Victor Tapias</italic></p>
</fn>
<corresp id="corr1">Address correspondence to: Dr. Solomon H. Snyder, The Solomon H. Snyder Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, MD 21205 <email>ssnyder@jhmi.edu</email></corresp>
<corresp id="corr2">Dr. Bindu D. Paul, The Solomon H. Snyder Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, MD 21205 <email>bpaul8@jhmi.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>10</day>
<month>4</month>
<year>2019</year>
<!--string-date: April 10, 2019-->
</pub-date>
<pub-date pub-type="epub">
<day>26</day>
<month>2</month>
<year>2019</year>
</pub-date>
<volume>30</volume>
<issue>11</issue>
<fpage>1450</fpage>
<lpage>1499</lpage>
<history>
<date date-type="received">
<day>10</day>
<month>8</month>
<year>2017</year>
<!--string-date: Date of first submission to ARS Central, August 10, 2017-->
</date>
<date date-type="rev-recd">
<day>16</day>
<month>3</month>
<year>2018</year>
<!--string-date: date of final revised submission, March 16, 2018-->
</date>
<date date-type="accepted">
<day>18</day>
<month>3</month>
<year>2018</year>
<!--string-date: date of acceptance, March 18, 2018-->
</date>
</history>
<permissions>
<copyright-statement>Copyright 2019, Mary Ann Liebert, Inc., publishers</copyright-statement>
<copyright-year>2019</copyright-year>
</permissions>
<self-uri content-type="pdf" xlink:href="ars.2017.7321.pdf" xlink:type="simple"></self-uri>
<abstract>
<title>Abstract</title>
<p><bold><italic>Significance:</italic></bold> Once considered to be mere by-products of metabolism, reactive oxygen, nitrogen and sulfur species are now recognized to play important roles in diverse cellular processes such as response to pathogens and regulation of cellular differentiation. It is becoming increasingly evident that redox imbalance can impact several signaling pathways. For instance, disturbances of redox regulation in the brain mediate neurodegeneration and alter normal cytoprotective responses to stress. Very often small disturbances in redox signaling processes, which are reversible, precede damage in neurodegeneration.</p>
<p><bold><italic>Recent Advances:</italic></bold> The identification of redox-regulated processes, such as regulation of biochemical pathways involved in the maintenance of redox homeostasis in the brain has provided deeper insights into mechanisms of neuroprotection and neurodegeneration. Recent studies have also identified several post-translational modifications involving reactive cysteine residues, such as nitrosylation and sulfhydration, which fine-tune redox regulation. Thus, the study of mechanisms <italic>via</italic> which cell death occurs in several neurodegenerative disorders, reveal several similarities and dissimilarities. Here, we review redox regulated events that are disrupted in neurodegenerative disorders and whose modulation affords therapeutic opportunities.</p>
<p><bold><italic>Critical Issues:</italic></bold> Although accumulating evidence suggests that redox imbalance plays a significant role in progression of several neurodegenerative diseases, precise understanding of redox regulated events is lacking. Probes and methodologies that can precisely detect and quantify <italic>in vivo</italic> levels of reactive oxygen, nitrogen and sulfur species are not available.</p>
<p><bold><italic>Future Directions:</italic></bold> Due to the importance of redox control in physiologic processes, organisms have evolved multiple pathways to counteract redox imbalance and maintain homeostasis. Cells and tissues address stress by harnessing an array of both endogenous and exogenous redox active substances. Targeting these pathways can help mitigate symptoms associated with neurodegeneration and may provide avenues for novel therapeutics.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords</title>
<kwd>cysteine</kwd>
<kwd>sulfhydration</kwd>
<kwd>reverse transsulfuration</kwd>
<kwd>free radicals</kwd>
<kwd>neurodegeneration</kwd>
<kwd>redox regulation</kwd>
</kwd-group>
<counts>
<fig-count count="15"></fig-count>
<table-count count="2"></table-count>
<equation-count count="3"></equation-count>
<ref-count count="573"></ref-count>
<page-count count="50"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>